{
    "Trade/Device Name(s)": [
        "MicroScan\u00ae Dried Gram-Positive MIC/Combo Panels with Ceftaroline (0.06-16 mcg/ml)",
        "Microdilution Minimum Inhibitory Concentration (MIC) Panels",
        "MicroScan Dried Gram-Positive MIC/Combo Panels"
    ],
    "Submitter Information": "Siemens Healthcare Diagnostics",
    "510(k) Number": "K123933",
    "Predicate Device Reference 510(k) Number(s)": [
        "K003619"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "LTT",
        "JWY",
        "LRG",
        "LTW"
    ],
    "Summary Letter Date": "December 17, 2012",
    "Summary Letter Received Date": "December 20, 2012",
    "Submission Date": "",
    "Regulation Number(s)": [
        "21 CFR 866.1640"
    ],
    "Regulation Name(s)": [
        "Antimicrobial Susceptibility Test Powder"
    ],
    "Analyte Class(es)": [
        "microbiology"
    ],
    "Analyte(s)": [
        "Ceftaroline"
    ],
    "Specimen Type(s)": [
        "Colonies grown on solid media of rapidly growing aerobic and facultative anaerobic gram-positive bacteria",
        "Staphylococcus aureus (skin isolates and community-acquired bacterial pneumonia isolates)"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [
        "autoSCAN\u00ae-4",
        "WalkAway\u00ae",
        "MicroScan instrumentation"
    ],
    "Method(s)/Technology(ies)": [
        "Broth dilution susceptibility test",
        "Manual reading",
        "Automated reading"
    ],
    "Methodologies": [
        "Minimum Inhibitory Concentration (MIC) determination",
        "Antimicrobial susceptibility testing"
    ],
    "Submission Type(s)": [
        "Panel"
    ],
    "Document Summary": "FDA 510(k) summary for Siemens MicroScan Dried Gram-Positive MIC/Combo Panels with added Ceftaroline for antimicrobial susceptibility testing of gram-positive bacteria.",
    "Indications for Use Summary": "Used to determine antimicrobial agent susceptibility for colonies of rapidly growing aerobic and facultative anaerobic gram-positive bacteria, specifically for Ceftaroline susceptibility in Staphylococcus aureus skin and community-acquired pneumonia isolates.",
    "fda_folder": "Microbiology"
}